Literature DB >> 19808286

Angina in fabry disease reflects coronary small vessel disease.

Cristina Chimenti1, Emanuela Morgante, Gaetano Tanzilli, Enrico Mangieri, Giuseppe Critelli, Carlo Gaudio, Matteo A Russo, Andrea Frustaci.   

Abstract

BACKGROUND: Chest pain is frequently reported in Fabry disease (FD). However, its mechanism and clinical relevance are unclear. METHODS AND
RESULTS: Basal troponin I level, exercise stress test, single-photon emission computed tomography imaging with (99m)Tc sestamibi, coronary angiography with thrombolysis in myocardial infarction (TIMI) frame count and left ventricular angiography and endomyocardial biopsy were obtained in 13 patients with FD with angina. Ratio of external to lumen diameter of intramural arteries (E/L ratio), myocyte diameter, and extent of fibrosis were morphometrically evaluated by using tissue sections. Controls for coronary angiography and histology were 25 patients with FD without angina and 20 mitral stenosis patients with normal left ventricular function. Troponin I level was elevated in 6 of the 13 patients. Exercise stress test showed evidence of myocardial ischemia, and single-photon emission computed tomography was positive for stress-induced perfusion defects in all patients with FD with angina. Epicardial coronaries were structurally normal but showed slow flow in all and were associated with aneurisms of posterior left ventricular wall in 3 cases. Histology showed remarkable lumen narrowing of most intramural arteries (mean E/L ratio=3.5+/-1.2; P<0.001 versus both control groups), because of hypertrophy and proliferation of smooth muscle and endothelial cells, both engulfed by glycosphingolipids. Replacement fibrosis exceeded that of both controls (P<0.001). Small vessel disease correlated with coronary slow flow and extent of fibrosis, but did not with patients' age, sex, and degree of left ventricular hypertrophy.
CONCLUSIONS: patients with FD with angina have perfusion defects, slow coronary flow, and luminal narrowing of intramural arteries. Small vessel disease may contribute to symptomatic limitation and progressive myocardial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19808286     DOI: 10.1161/CIRCHEARTFAILURE.108.769729

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  21 in total

Review 1.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

Review 2.  Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new α-galactosidase mutation of Leu311Arg (L311R).

Authors:  Keisuke Suzuki; Naoto Miura; Wataru Kitagawa; Shinkichi Suzuki; Atsushi Komatsuda; Kazuhiro Nishikawa; Daisuke Watanabe; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2011-07-15       Impact factor: 2.801

Review 3.  Microvascular dysfunction in infiltrative cardiomyopathies.

Authors:  Ornella Rimoldi; Francesco Maranta
Journal:  J Nucl Cardiol       Date:  2017-07-11       Impact factor: 5.952

4.  Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry disease.

Authors:  Markus Niemann; Tanja Hartmann; Mehdi Namdar; Frank Breunig; Meinrad Beer; Wolfram Machann; Sebastian Herrmann; Georg Ertl; Christoph Wanner; Frank Weidemann
Journal:  J Inherit Metab Dis       Date:  2012-10-11       Impact factor: 4.982

Review 5.  Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.

Authors:  Marco Giuseppe Del Buono; Rocco A Montone; Massimiliano Camilli; Salvatore Carbone; Jagat Narula; Carl J Lavie; Giampaolo Niccoli; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2021-09-28       Impact factor: 24.094

6.  Quantitative Myocardial Perfusion in Fabry Disease.

Authors:  Kristopher D Knott; Joao B Augusto; Sabrina Nordin; Rebecca Kozor; Claudia Camaioni; Hui Xue; Rebecca K Hughes; Charlotte Manisty; Louise A E Brown; Peter Kellman; Uma Ramaswami; Derralyn Hughes; Sven Plein; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2019-07-04       Impact factor: 7.792

Review 7.  Fabry Disease and the Heart: A Comprehensive Review.

Authors:  Olga Azevedo; Filipa Cordeiro; Miguel Fernandes Gago; Gabriel Miltenberger-Miltenyi; Catarina Ferreira; Nuno Sousa; Damião Cunha
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

8.  Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study.

Authors:  Cristina Chimenti; Luca Padua; Costanza Pazzaglia; Emanuela Morgante; Carlos Centurion; Daniela Antuzzi; Matteo A Russo; Andrea Frustaci
Journal:  Hum Pathol       Date:  2012-03-08       Impact factor: 3.466

9.  Persistent increase in cardiac troponin I in Fabry disease: a case report.

Authors:  Christian Tanislav; Andreas Feustel; Wolfgang Franzen; Oliver Wüsten; Christian Schneider; Frank Reichenberger; Arndt Rolfs; Nicole Sieweke
Journal:  BMC Cardiovasc Disord       Date:  2011-01-31       Impact factor: 2.298

Review 10.  Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future.

Authors:  Roberta Esposito; Ciro Santoro; Giulia Elena Mandoli; Vittoria Cuomo; Regina Sorrentino; Lucia La Mura; Maria Concetta Pastore; Francesco Bandera; Flavio D'Ascenzi; Alessandro Malagoli; Giovanni Benfari; Antonello D'Andrea; Matteo Cameli
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.